+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Morocco Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flower, Oil & Tinctures), By Application (Chronic Pain, Tourette's Syndrome, Cancer, Depression & Anxiety), And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 70 Pages
  • June 2023
  • Region: Morocco
  • Grand View Research
  • ID: 5846757
The Morocco medical cannabis market size is expected to reach USD 537.70 million by 2030, registering a CAGR of 48.0% during the forecast period, based on a new report by the publisher. The medical cannabis market in Morocco is witnessing substantial growth due to various factors. The legalization and regulation of cannabis production and export have created opportunities for domestic cultivation and the development of a thriving industry. Additionally, there is a rising global demand for medical cannabis, driven by the increasing acceptance and recognition of its therapeutic potential. Furthermore, the medical cannabis market presents economic opportunities, attracting investments and generating jobs in the cultivation and manufacturing sectors.

The growing demand for marijuana is one of the main growth drivers for Morocco's medical cannabis industry. The country has a long history of marijuana cultivation in the northern region, making it one of the largest producers in the world. However, the industry has traditionally been informal and unregulated. Recognizing the potential economic benefits, the Moroccan government has taken steps to legalize and regulate the cannabis sector, responding to the global demand for legal marijuana.

The adoption of marijuana is on the rise, fueled by increased awareness of its medical benefits and easy availability. In countries where marijuana has been legalized or decriminalized, illegal purchases have decreased as more people opt for legal channels to obtain marijuana for medical purposes. Moreover, legalization offers governments an opportunity to generate revenue through taxation, which can then be utilized for various development programs in education and infrastructure. As a result, the legalization of marijuana has spurred demand in these countries, mitigating the impact of the illicit market.

However, the growth of the market in Morocco may face obstacles with the legalization of cannabis for selected indications. Regulatory restrictions on usage, production, and distribution, including limited patient access, strict licensing requirements, and limitations on product types, have the potential to hinder market expansion. The complex and time-consuming process of obtaining regulatory approvals may discourage new entrants and stifle innovation within the industry. Furthermore, the medical community's acceptance and understanding of marijuana are still evolving, and public perception and stigma surrounding cannabis use, even for medical purposes, can impede widespread adoption and patient demand.

Despite these challenges, as regulatory frameworks mature, research advances and awareness grows, the overall growth potential of the market in Morocco remains promising. With the government's recognition of the industry's economic benefits and the increasing demand for marijuana worldwide, the market has the opportunity to thrive in the long run, benefiting patients, businesses, and the overall economy.

Morocco Medical Cannabis Market Report Highlights

  • Based on product, the market is segmented into flowers, oils & tinctures. The oils & tinctures segment held the majority of the revenue share of 51.3% in 2022
  • The oils & tinctures segment is expected to grow at the fastest CAGR of 48.8% over the forecast period
  • Based on application, chronic pain held the majority share of 27.3% in 2022. Its growth can be attributed to research indicating the beneficial effects of marijuana in mitigating pain and the significant incidence of chronic pain
  • The Tourette’s syndrome segment is expected to grow at a significant CAGR of 54.0% during the forecast period, owing to an increasing number of patients exploring the potential benefits of marijuana-based treatments

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Scope and Assumptions
1.3 Research Methodology
1.4 Research Methodology
1.5 Research Workflow
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary sources:
1.6.4 Third-Party Perspective:
1.6.5 Primary Research
1.7 Information Analysis & Data Analysis Models
1.7.1 Market Formulation & Validation
1.8 List of Data Sources
Chapter 2 Executive Summary
2.1 Morocco Medical Cannabis Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Morocco Medical Cannabis Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Growing ADoption of Medical Marijuana for Treatment of Chronic Diseases
3.1.1.2 Elimination of Black Market Through Legalization
3.1.1.3 Growing Cannabis Tourism in the Country
3.1.2 Market Restraint Analysis
3.1.2.1 Lower Market Access of Marijuana Due to Absence of Legalization Programs
3.1.2.2 High Pricing of Medical Marijuana in Big & Established Markets
3.1.2.3 Legalization of Medical Cannabis for Selected Indications
3.1.3 Penetration and Growth Prospect Mapping
3.2 History of Medical Use of Cannabis
3.3 Morocco Medical Cannabis Market Analysis Tools
3.3.1 Morocco Medical Cannabis market - PESTLE Analysis
3.3.1.1 Political & Legal Landscape
3.3.1.2 Economic Landscape
3.3.1.3 Social Landscape
3.3.1.4 Technology Landscape
3.3.2 Morocco Medical Cannabis market - Porter’s Analysis
3.3.3 Supplier Power: Moderate
3.3.4 Buyer Power: Low
3.3.5 Substitution Threat: Moderate
3.3.6 Threat of New Entrants: Low
3.3.7 Competitive Rivalry: High
3.4 COVID-19 Impact on Morocco Medical Cannabis Market
3.5 Morocco Medical Cannabis Scenario and Insights
3.5.1 The Scale of the Moroccan Cannabis Industry
3.5.2 Cannabis Legalization and Cannabis Industry Future
3.5.3 Regulatory Scenario
3.5.4 Cannabis Illegal Trade Routes
3.6 Role of Cannabis License Holders and Their Relation with Farmers and Producers
3.7 Global Companies and Their Market Entry Strategies for the African Cannabis Industry
Chapter 4 Morocco Medical Cannabis Market: Product Estimates & Trend Analysis
4.1 Morocco Medical Cannabis Market: Product Movement Analysis, 2022 & 2030, USD Million
4.2 Flower
4.2.1 FLower market estimates and Forecasts, 2022 - 2030 (USD Million)
4.3 Oil and Tinctures
4.3.1 Oil and Tinctures market estimates and Forecasts, 2022 - 2030(USD Million)
Chapter 5 Morocco Medical Cannabis Analytics Market: Application Estimates & Trend Analysis
5.1 Morocco Medical Cannabis Market: Application Movement Analysis, 2022 & 2030, USD Million
5.2 Cancer
5.2.1 Cancer market estimates and Forecasts, 2022 - 2030 (USD Million)
5.2.2 Morocco Estimated cancer prevalence estimates and Forecasts, 2018 - 2030
5.3 Chronic Pain
5.3.1 Chronic pain market estimates and Forecasts, 2022 - 2030 (USD Million)
5.3.2 Morocco Estimated chronic pain prevalence estimates and Forecasts, 2018 - 2030 (Million)
5.4 Anxiety & Depression
5.4.1 Anxiety & depression market estimates and Forecasts, 2022 - 2030 (USD Million)
5.4.2 Morocco Estimated depressive disorders prevalence estimates and Forecasts, 2018 - 2030 (Million)
5.5 Arthritis
5.5.1 Arthritis market estimates and Forecasts, 2022 - 2030 (USD Million)
5.5.2 Morocco Estimated arthritis prevalence estimates and Forecasts, 2018 - 2030
5.6 Diabetes
5.6.1 Diabetes market estimates and Forecasts, 2022 - 2030 (USD Million)
5.6.2 Morocco Estimated diabetes mellitus prevalence estimates and Forecasts, 2018 - 2030 (Million)
5.7 Glaucoma
5.7.1 glaucoma market estimates and Forecasts, 2022 - 2030 (USD Million)
5.7.2 Morocco Estimated glaucoma prevalence estimates and Forecasts, 2018 - 2030
5.8 Migraines
5.8.1 Migraines market estimates and Forecasts, 2022 - 2030 (USD Million)
5.8.2 Morocco Estimated migraines prevalence estimates and Forecasts, 2018 - 2030 (Million)
5.9 Epilepsy
5.9.1 epilepsy market estimates and Forecasts, 2022 - 2030 (USD Million)
5.9.2 Morocco Estimated epilepsy prevalence estimates and Forecasts, 2018 - 2030
5.10 Multiple Sclerosis
5.10.1 Multiple sclerosis market estimates and Forecasts, 2022 - 2030 (USD Million)
5.10.2 Morocco Estimated multiple sclerosis prevalence estimates and Forecasts, 2018 - 2030
5.11 AIDS
5.11.1 AIDS market estimates and Forecasts, 2022 - 2030 (USD Million)
5.11.2 Morocco Estimated AIDS prevalence estimates and Forecasts, 2018 - 2030
5.12 Amyotrophic Lateral Sclerosis
5.12.1 Amyotrophic lateral sclerosis market estimates and Forecasts, 2022 - 2030 (USD Million)
5.12.2 Morocco Estimated motor neuron disease prevalence estimates and Forecasts, 2018 - 2030
5.13 Alzheimer’s
5.13.1 Alzheimer’s market estimates and Forecasts, 2022 - 2030 (USD Million)
5.13.2 Morocco Estimated ALzheimer’s and dementia prevalence estimates and Forecasts, 2018 - 2030
5.14 Post-Traumatic Stress Disorder (PTSD)
5.14.1 PTSD market estimates and Forecasts, 2022 - 2030 (USD Million)
5.14.2 Morocco Estimated PTSD prevalence estimates and Forecasts, 2018 - 2030 (Million)
5.15 Parkinson’s
5.15.1 Parkinson’s market estimates and Forecasts, 2022 - 2030 (USD Million)
5.15.2 Morocco Estimated Parkinson’s prevalence estimates and Forecasts, 2018 - 2030
5.16 Tourette’s
5.16.1 Tourette’s market estimates and Forecasts, 2022 - 2030 (USD Million)
5.16.2 Morocco Estimated Tourette’s prevalence estimates and Forecasts, 2018 - 2030
5.17 Others
5.17.1 others market estimates and Forecasts, 2022 - 2030 (USD Million)
Chapter 6 Competitive Landscape and Analysis
6.1 Company Profiles
6.1.1 Participant’s overview
6.1.2 Product Benchmarking
6.1.3 Strategic Initiatives
6.1.4 COMPANY MARKET POSITION ANALYSIS
6.2 List of other companies
List of Tables
Table 1: List of secondary sources
Table 2: Morocco medical cannabis market, by type, 2022-2030 (USD Million)
Table 3: Morocco medical cannabis market, by application, 2022-2030 (USD Million)
List of Figures
Fig. 1: Morocco medical cannabis market segmentation
Fig. 2: Estimation Methodology
Fig. 3: Various stages of the research workflow
Fig. 4: Information procurement
Fig. 5: Primary research pattern
Fig. 6: Market Formulation & Validation
Fig. 7: Morocco medical cannabis market summary, 2022 (USD Million)
Fig. 8: Morocco medical cannabis market: Segment Summary, 2022 (USD Million)
Fig. 9: Morocco medical cannabis market: Competitive Landscape (USD Million)
Fig. 10: Penetration & growth prospect mapping for the product segment, 2022
Fig. 11: History of industrial and medical use of cannabis in Morocco
Fig. 12: History of industrial and medical use of cannabis in Morocco
Fig. 13: Morocco medical cannabis market: Product outlook key takeaways, USD Million
Fig. 14: Morocco medical cannabis market: Product movement analysis, 2022 & 2030
Fig. 15: Flower market estimates and forecasts, 2022-2030 (USD Million)
Fig. 16: Oil and tinctures market estimates and forecasts, 2022-2030 (USD Million)
Fig. 17: Morocco medical cannabis market, Application outlook key takeaways, USD Million
Fig. 18: Morocco medical cannabis market: Application movement analysis, 2022 & 2030 (USD Million)
Fig. 19: Cancer market estimates and forecasts, 2022-2030 (USD Million)
Fig. 20: Morocco estimated cancer prevalence estimates and forecasts, 2018-2030
Fig. 21: Chronic pain market estimates and forecasts, 2022-2030 (USD Million)
Fig. 22: Morocco estimated chronic pain prevalence estimates and forecasts, 2018-2030 (Million)
Fig. 23: Anxiety & depression market estimates and forecasts, 2022-2030 (USD Million)
Fig. 24: Morocco estimated depressive disorders prevalence estimates and forecasts, 2018-2030 (Million)
Fig. 25: Arthritis market estimates and forecasts, 2022-2030 (USD Million)
Fig. 26: Morocco estimated arthritis prevalence estimates and forecasts, 2018-2030
Fig. 27: Diabetes market estimates and forecasts, 2022-2030 (USD Million)
Fig. 28: Morocco estimated diabetes mellitus prevalence estimates and forecasts, 2018-2030 (Million)
Fig. 29: Glaucoma market estimates and forecasts, 2022-2030 (USD Million)
Fig. 30: Morocco estimated glaucoma prevalence estimates and forecasts, 2018-2030
Fig. 31: Migraines market estimates and forecasts, 2022-2030 (USD Million)
Fig. 32: Morocco estimated migraines prevalence estimates and forecasts, 2018-2030 (Million)
Fig. 33: Epilepsy market estimates and forecasts, 2022-2030 (USD Million)
Fig. 34: Morocco estimated epilepsy prevalence estimates and forecasts, 2018-2030
Fig. 35: Multiple sclerosis market estimates and forecasts, 2022-2030 (USD Million)
Fig. 36: Morocco estimated multiple sclerosis prevalence estimates and forecasts, 2018-2030
Fig. 37: AIDS market estimates and forecasts, 2022-2030 (USD Million)
Fig. 38: Morocco estimated AIDS prevalence estimates and forecasts, 2018-2030
Fig. 39: Amyotrophic lateral sclerosis market estimates and forecasts, 2022-2030 (USD Million)
Fig. 40: Morocco estimated motor neuron disease prevalence estimates and forecasts, 2018-2030
Fig. 41: Alzheimer’s market estimates and forecasts, 2022-2030 (USD Million)
Fig. 42: Morocco estimated Alzheimer’s and dementia prevalence estimates and forecasts, 2018-2030
Fig. 43: PTSD market estimates and forecasts, 2022-2030 (USD Million)
Fig. 44: Morocco estimated PTSD prevalence estimates and forecasts, 2018-2030 (Million)
Fig. 45: Parkinson’s market estimates and forecasts, 2022-2030 (USD Million)
Fig. 46: Morocco estimated Parkinson’s prevalence estimates and forecasts, 2018-2030
Fig. 47: Tourette’s market estimates and forecasts, 2022-2030 (USD Million)
Fig. 48: Morocco estimated Tourette’s prevalence estimates and forecasts, 2018-2030
Fig. 49: Others market estimates and forecasts, 2022-2030 (USD Million)
Fig. 50: Company market position analysis

Companies Mentioned

  • Bio Cannat
  • PharmaCielo Ltd

Methodology

Loading
LOADING...